Oric Pharmaceuticals (ORIC) Earnings Date & Reports
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
ORIC is expected to report earnings to rise 20.48% to -50 cents per share on August 07
Q2'25
Est.
$-0.51
Q1'25
Beat
by $0.09
Q4'24
Missed
by $0.01
Q3'24
Missed
by $0.01
Q2'24
Missed
by $0.04
The last earnings report on May 05 showed earnings per share of -41 cents, beating the estimate of -50 cents. With 418.64K shares outstanding, the current market capitalization sits at 361.13M.